Influence of drug formulation on utilization and outcomes: Neoral and monitoring by sparse sample area under the curve.
D000208:Acute Disease; D019540:Area Under Curve; D002626:Chemistry, Pharmaceutical; D016572:Cyclosporine / Q000008:administration & dosage / Q000493:pharmacokinetics*; D016903:Drug Monitoring; D006084:Graft Rejection / Q000517:prevention & control; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000493:pharmacokinetics*; D016030:Kidney Transplantation / Q000276:immunology; D013810:Therapeutic Equivalency; D016896:Treatment Outcome